Cediranib Maleate and Whole Brain Radiation Therapy in Patients With Brain Metastases From Non-Small Cell Lung Cancer

NCT00937482 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

18

Enrollment

NIH

Sponsor class

Stopped Administratively complete.

Conditions

Male Breast Cancer
Stage IV Breast Cancer
Stage IV Melanoma
Stage IV Non-small Cell Lung Cancer
Stage IV Renal Cell Cancer
Stage IVA Colon Cancer
Stage IVA Rectal Cancer
Stage IVB Colon Cancer
Stage IVB Rectal Cancer
Tumors Metastatic to Brain

Interventions

DRUG: cediranib maleate
RADIATION: whole-brain radiation therapy

Sponsor

National Cancer Institute (NCI)